[1]
“Safety of Metformin Continuation During Peri-Procedural Period of Coronary Angiography in Type 2 Diabetic Patients”, Adv.med.j., vol. 10, no. 4, pp. 97–103, Dec. 2025, doi: 10.56056/403.